AIM
IDYA icon

Aigen Investment Management’s IDEAYA Biosciences IDYA Stock Holding History

Aigen Investment Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,899
Closed -$280K – 873
2024
Q4 		$280K Buy
+10,899
New +$309K 0.05% 500
2024
Q3 		– Sell
-12,420
Closed -$436K – 856
2024
Q2 		$436K Buy
+12,420
New +$492K 0.08% 350
2023
Q4 		– Sell
-8,950
Closed -$241K – 919
2023
Q3 		$241K Buy
+8,950
New +$227K 0.05% 603

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aigen Investment Management's IDYA Position: Q1 2025 in Review

Aigen Investment Management sold out of IDEAYA Biosciences (IDYA) in Q1 2025, closing a stake of 10,899 shares — an estimated $280K sold.

Aigen Investment Management first reported a position in IDYA in Q3 2023 and held it in 3 quarters. The position peaked at $436K in Q2 2024. 207 funds tracked by Wall St. Rank hold IDYA as of Q1 2025.

  • Aigen Investment Management reported no remaining IDEAYA Biosciences position as of Q1 2025 after selling out during the quarter.
  • Aigen Investment Management sold 10,899 IDEAYA Biosciences shares in Q1 2025, an estimated $280K.
  • Aigen Investment Management first reported a position in IDEAYA Biosciences in Q3 2023 and held it in 3 quarters.
  • Aigen Investment Management's IDEAYA Biosciences position peaked at $436K in Q2 2024.
  • 207 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2025.

Based on Aigen Investment Management's 13F filing for Q1 2025, filed 12 May 2025.